back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2024-02-08 10:06 Tx date 2024-02-05 |
$APS
Aptose Biosciences Inc. |
Vincent, Mark
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+3,333 vol |
40,227 | |
| Filed 2023-08-17 20:53 Tx date 2023-05-24 |
$APS
Aptose Biosciences Inc. |
Vincent, Mark
4 - Director of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-521,189 vol |
36,894 | |
| Filed 2023-08-17 20:52 Tx date 2023-05-24 |
$APS
Aptose Biosciences Inc. |
Vincent, Mark
4 - Director of Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
-6,067 vol |
433 | |
| Filed 2023-01-24 15:53 Tx date 2023-01-19 |
$APS
Aptose Biosciences Inc. |
Vincent, Mark
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+100,000 vol |
558,083 | |
| Filed 2022-01-20 18:44 Tx date 2022-01-18 |
$APS
Aptose Biosciences Inc. |
Vincent, Mark
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+50,000 vol |
458,083 | |
| Filed 2021-01-06 19:52 Tx date 2021-01-04 |
$APS
Aptose Biosciences Inc. |
Vincent, Mark
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+50,000 vol |
408,083 | |
| Filed 2020-03-14 13:51 Tx date 2020-03-11 |
$APS
Aptose Biosciences Inc. |
Vincent, Mark
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+50,000 vol |
358,083 | |
| Filed 2020-02-03 11:17 Tx date 2020-01-31 |
$APS
Aptose Biosciences Inc. |
Vincent, Mark
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+154,000 vol |
308,083 | |
| Filed 2019-01-03 Tx date 2019-01-02 |
$APS
Aptose Biosciences Inc. |
Vincent, Mark
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+40,000 vol |
154,083 | |
| Filed 2018-01-23 Tx date 2018-01-19 |
$APS
Aptose Biosciences Inc. |
Vincent, Mark
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+60,000 vol |
114,083 | |
| Filed 2017-06-30 Tx date 2017-06-28 |
$APS
Aptose Biosciences Inc. |
Vincent, Mark
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+5,000 vol |
6,500 | |
| Filed 2017-06-30 Tx date 2017-06-28 |
$APS
Aptose Biosciences Inc. |
Vincent, Mark
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-5,000 vol |
0 | |
| Filed 2017-06-09 Tx date 2017-06-06 |
$APS
Aptose Biosciences Inc. |
Vincent, Mark
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$6,899
+5,000 vol $1.38 each |
54,083 | |
| Filed 2017-03-31 Tx date 2017-03-28 |
$APS
Aptose Biosciences Inc. |
Vincent, Mark
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+10,000 vol |
49,083 | |
| Filed 2017-03-31 Tx date 2007-09-19 |
$APS
Aptose Biosciences Inc. |
Vincent, Mark
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2017-03-31 Tx date 2017-03-28 |
$APS
Aptose Biosciences Inc. |
Vincent, Mark
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+5,000 vol |
5,000 | |
| Filed 2016-04-04 Tx date 2016-03-31 |
$APS
Aptose Biosciences Inc. |
Vincent, Mark
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$38,200
+10,000 vol $3.82 each |
||
| Filed 2016-04-04 Tx date 2016-03-31 |
$APS
Aptose Biosciences Inc. |
Vincent, Mark
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$38,200
+10,000 vol $3.82 each |
39,083 | |
| Filed 2015-11-24 Tx date 2015-11-24 |
$APS
Aptose Biosciences Inc. |
Vincent, Mark
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$3,150
+1,000 vol $3.15 each |
1,500 | |
| Filed 2015-06-22 Tx date 2007-09-19 |
$APS
Aptose Biosciences Inc. |
Vincent, Mark
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2015-06-22 Tx date 2015-06-19 |
$APS
Aptose Biosciences Inc. |
Vincent, Mark
4 - Director of Issuer
Direct Ownership
|
Warrants
54 - Exercise of warrants
|
$-1,500
-500 vol $3.00 each |
0 | |
| Filed 2015-06-22 Tx date 2014-10-10 |
$APS
Aptose Biosciences Inc. |
Vincent, Mark
4 - Director of Issuer
Direct Ownership
|
Warrants
37 - Stock split or consolidation
|
-5,500 vol |
500 | |
| Filed 2015-06-22 Tx date 2015-06-19 |
$APS
Aptose Biosciences Inc. |
Vincent, Mark
4 - Director of Issuer
Direct Ownership
|
Common Shares
54 - Exercise of warrants
|
$1,500
+500 vol $3.00 each |
500 |